Akso Health Group
Akso Health Group (AHG) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ahg · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Akso Health Group (AHG) measures how much investors pay for each dollar of the company's trailing earnings. AHG's current PE ratio of N/A is calculated by dividing its stock price of $1.33 by its TTM earnings per share of -$0.40.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%51.4x
MedianQ3 · 75%171.5x
Max
At N/A, AHG's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Financial - Credit Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Akso Health GroupYou AHG | $126M | N/A | — | -$0.40 |
 Binah Capital Group, Inc. BCG | $27M | 20.79x | -88.2% | $0.14 |
 Equus Total Return, Inc. EQS | $18M | N/A | — | -$1.03 |
 Greenidge Generation Holdings Inc. GREE | $26M | 3.66x | -97.9% | $0.40 |
 U.S. Global Investors, Inc. GROW | $35M | N/A | — | -$0.03 |
 Gores Holdings X, Inc. GTEN | $470M | 501.83x | +186.1% | $0.02 |
 MDB Capital Holdings, LLC Class A common MDBH | $30M | N/A | — | -$2.12 |
Industry Average 3 peers with valid PE | — | 175.43x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-0.47 | — | |
2024-03-31 FY2024 | — | $-0.45 | — | |
2023-03-31 FY2023 | — | $-0.18 | — | |
2022-03-31 FY2022 | — | $-2.54 | — | |
2021-03-31 FY2021 | — | $-6.42 | — | |
2020-03-31 FY2020 | — | $-13.14 | — | |
2019-03-31 FY2019 | 31.94x | $0.94 | +288.1% | |
2018-03-31 FY2018 | 8.23x | $12.37 | -88.4% | |
2017-03-31 FY2017 | 70.78x | $1.61 | -58.7% | |
2016-03-31 FY2016 | 171.46x | $0.66 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Akso Health Group (AHG) measures how much investors pay for each dollar of the company's trailing earnings. AHG's current PE ratio of N/A is calculated by dividing its stock price of $1.33 by its TTM earnings per share of -$0.40.
Frequently asked questions
AHG pe ratio · 6 questionsAHG's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.33 and TTM EPS of -$0.40. Data sourced from Financial Modeling Prep via AHG's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Akso Health Group SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09